SUBSCRIBE
SUBSCRIBE

mRNA

Bio NC
Study Reveals Huge Potential for mRNA Drug Targets
Companies that have a strong focus on developing drugs that target messenger RNA (mRNA) may be ahead of the curve when it comes to potentially tapping into a lucrative market space.
March 19, 2018
 · 
2 min read
 · 
Alex Keown
Gemini Therapeutics Banks $42.5M to Bring Precisio
BioCapital
The Biggest Winners and Losers of JPM 2018
With the J.P. Morgan Healthcare Conference now over, some analysts are looking back and picking out the “winners and losers” from the conference.
January 17, 2018
 · 
3 min read
 · 
Alex Keown
Drug Development
With Merck Footing the $200M Bill, Moderna Launches mRNA Cancer Vaccine Clinical Trial
Moderna announced that it has dosed its first patient in a Phase I trial of mRNA-4157, a mRNA-based personalized cancer vaccine.
November 15, 2017
 · 
3 min read
 · 
Mark Terry
Business
Secretive Moderna Inks mRNA Heart Failure Deal With AstraZeneca
The companies will advance the new Relaxin development candidate, AZD7970, toward the clinic as an investigational treatment for heart failure.
November 1, 2017
 · 
4 min read
Business
Eli Lilly Strikes $1.8B mRNA R&D Pact With CureVac
Eli Lilly has signed a collaboration deal with CureVac that could total up to $1.8B.
October 18, 2017
 · 
2 min read
 · 
Mark Terry
AstraZeneca PLC Offloads Remaining Anesthetics Portfolio in $766 Million Deal
Business
AstraZeneca PLC Jumps Deeper Into mRNA Drugs With Ethris Deal
August 21, 2017
 · 
3 min read
Genentech Grows on Promise of 70+ Drug Approvals
Business
Genentech Gambles $310 Million+ on German Biotech BioNTech’s mRNA Cancer Vaccine Tech
September 21, 2016
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Vertex and Moderna Hammer Out $315 Million+ Deal to Treat Cystic Fibrosis Using mRNA Technology
July 6, 2016
 · 
3 min read
Pfizer and Allergan Execs Emphasize Joint Company’s Pipeline, Hint Job Cuts Will Be Minimal
Biotech Bay
Gilead Should Have Investors Giddy Over Continued HCV Dominance at J.P. Morgan
January 13, 2016
 · 
4 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Engineered mRNA Company Moderna Launches 4th Spinoff, Caperna
October 22, 2015
 · 
3 min read
Load More
PRESS RELEASES
Press Releases
CMUH and Partners Unveil Breakthrough Targeted Exosome Platform for Non-Invasive Spinal Cord Injury Repair
April 24, 2026
 · 
5 min read
Press Releases
Moderna Announces Initiation of Phase 3 Study of Investigational mRNA Pandemic Influenza Vaccine Candidate
April 22, 2026
 · 
4 min read
Press Releases
Remix Therapeutics Announces Oral Presentation of First-in-Class Small Molecule MYB mRNA Degrader REM-422 Phase 1/2 ARIA Trial Results at the 2026 American Society of Clinical Oncology Annual Meeting
April 21, 2026
 · 
3 min read
Press Releases
Moderna Receives European Commission Marketing Authorization for mCOMBRIAX, Moderna’s mRNA Combination Vaccine Against Influenza and COVID-19
April 21, 2026
 · 
6 min read
Press Releases
Flagship Pioneering Launches Serif Biomedicines to Establish Modified DNA as a New Biotechnology
April 21, 2026
 · 
5 min read
Press Releases
AACR 2026 Oral Presentation: Abogen Presents Preliminary Results of ABO2203 (mRNA-Encoded CD3×CD19 TCE) from First-in-Human Clinical Study in R/R B-NHL
April 20, 2026
 · 
5 min read
Press Releases
Eclipsebio Launches eCOMPASS™, an AI-Enabled Lab-in-the-Loop Platform for RNA Therapeutic Development
April 20, 2026
 · 
3 min read
Press Releases
Genflow Biosciences PLC Announces Strategic Technology Collaboration
April 20, 2026
 · 
7 min read
Press Releases
Moderna to Present Phase 1/2 Data on Its Investigational Cancer Antigen Therapy mRNA-4359 as First-Line Therapy in Combination with Pembrolizumab in Locally Advanced or Metastatic Melanoma at the 2026 AACR Annual Meeting
April 20, 2026
 · 
6 min read
Press Releases
CREATE Medicines to Showcase Multi-immune In Vivo CAR T, CAR NK, and All-RNA RetroT Platform at AACR 2026
April 19, 2026
 · 
3 min read
Press Releases
STORM Therapeutics Secures $56 Million Series C Financing and Doses First Patient in Phase 2 Sarcoma Trial of STC‑15
April 16, 2026
 · 
3 min read
Press Releases
Alida Biosciences Launches EpiPlex® Tri-Mod™ Service for Simultaneous Profiling of Three Key mRNA Modifications
April 16, 2026
 · 
3 min read
Press Releases
Wobble Genomics to Present Novel mRNA Sequencing Research at AACR 2026
April 15, 2026
 · 
1 min read
Press Releases
Sanofi becomes market authorization holder for Nuvaxovid® in Canada, expanding COVID-19 vaccine choices for Canadians
April 10, 2026
 · 
4 min read
Press Releases
Moderna to Present Revaccination Data for Its Investigational Seasonal Influenza Vaccine and for mRESVIA at ESCMID 2026
April 7, 2026
 · 
8 min read
Press Releases
4basebio announces major expansion to support the growing demand of RUO and HQ synthetic DNA with lease of an innovation hub and manufacturing facility in Cambridge, UK
March 31, 2026
 · 
3 min read
Press Releases
CancerVax Reports Successful Initial Mouse Study with Breakthrough Results
March 31, 2026
 · 
6 min read
Press Releases
Sarepta Announces First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1
March 25, 2026
 · 
9 min read
Press Releases
Remix Therapeutics Granted FDA Fast Track Designation for REM-422 for the Treatment of Recurrent, Metastatic or Unresectable Adenoid Cystic Carcinoma
March 19, 2026
 · 
4 min read
Press Releases
Aro Biotherapeutics Reports Positive Phase 1b Topline Results for ABX1100, a Muscle-targeted GYS1 siRNA, in Patients with Late-Onset Pompe Disease (LOPD)
March 17, 2026
 · 
6 min read
Load More